NEW YORK, NY / ACCESSWIRE / October 16, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Anaplan Inc. (NYSE:PLAN)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/anaplan-inc-loss-submission-form?prid=10245&wire=1
Lead Plaintiff Deadline: October 23, 2020
Class Period: November 21, 2019 - February 26, 2020
Allegations against PLAN include that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.
Portland General Electric Company (NYSE:POR)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/portland-general-electric-company-loss-submission-form?prid=10245&wire=1
Lead Plaintiff Deadline: November 2, 2020
Class Period: April 24, 2020 - August 24, 2020
Allegations against POR include that: (1) PGE lacked effective internal controls over its energy trading practices; (2) PGE personnel had entered energy trades during 2020, with increasing volume accumulating late in the second quarter and into the third quarter, that created significant negative financial exposure for PGE; (3)as a result, the Company was reasonably likely to incur significant losses; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/fennec-pharmaceuticals-inc-loss-submission-form?prid=10245&wire=1
Lead Plaintiff Deadline: November 2, 2020
Class Period: February 11, 2020 - August 10, 2020
Allegations against FENC include that: (1) the manufacturing facilities for PEDMARK, the Company's sole product candidate, did not comply with current good manufacturing practices; (2) as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong